Remove Artificial Intelligence Remove Development Remove Pharmaceuticals
article thumbnail

AI can predict human response to drug compounds

Dataconomy

A CUNY Graduate Center research team has created CODE-AE, an artificial intelligence model that may dramatically improve accuracy and reduce the time and cost of pharmaceutical development. The therapeutic effect in a disease model may not necessarily correspond to pharmaceutical efficacy and toxicity in actual patients.

article thumbnail

Can developer productivity be measured? Better than you think

CIO Business Intelligence

Measuring developer productivity has long been a Holy Grail of business. In 2020, McKinsey surveyed 440 large companies about their “ developer velocity” — meaning the practices that best tap the full potential of development talent. Right now, there are roughly 27 million developers on the job, 4.4 That isn’t easy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biggest roadblocks that AI-powered drug development faced in 2022

Dataconomy

AI-powered drug development can shorten the time it takes to acquire and access information, cutting pharmaceutical development time in half and keeping the cost of new medications under control. This is becoming increasingly crucial as the cost of discovering and developing new drugs rises.

article thumbnail

Alphabet is launching a company that uses AI for drug discovery

The Verge

A new Alphabet company will use artificial intelligence methods for drug discovery, Google’s parent company announced Thursday. The new company, called Isomorphic Laboratories, will leverage that success to build tools that can help identify new pharmaceuticals. Photo by Micah Singleton / The Verge.

Company 130
article thumbnail

Tech Moves: Top Blue Origin engineer joins SpaceX; Axon hires HTC Vive exec; Porch adds to board

GeekWire

New Athira execs Mark Worthington, general counsel, and Rachel Lenington, chief technology officer and head of product development strategy. Athira Pharma recently appointed Rachel Lenington as CTO and head of product development strategy and Mark Worthington as general counsel. Athira Photos). The Bothell, Wash.-based Read the story.

CTO Hire 137
article thumbnail

University of Washington’s David Baker wins Nobel Prize for solving protein puzzles

GeekWire

” “His research group has produced one imaginative protein creation after another, including proteins that can be used as pharmaceuticals, vaccines, nanomaterials and tiny sensors,” the academy said. billion to acquire a different spinout, Icosavax , which develops synthetic vaccines that target naturally occurring viruses.

article thumbnail

The startups Nvidia thinks are the future of AI

Dataconomy

Nvidia has expanded its influence in the artificial intelligence (AI) sector by investing in six emerging AI companies. Nvidia builds AI portfolio with investments in six startups Nvidia’s investments include Applied Digital Corp , Arm Holdings , Nano-X Imaging , Recursion Pharmaceuticals , Serve Robotics , and SoundHound AI.